Cargando…

Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders

Severe acute respiratory syndrome coronavirus-2 has emerged as a new viral pandemic, causing Coronavirus disease 2019 (COVID-19) leading to a wide array of symptoms ranging from asymptomatic to severe respiratory failure. However, coagulation disorders have been found in some patients infected with...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alam, Walid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989108/ https://www.ncbi.nlm.nih.gov/pubmed/33815798 http://dx.doi.org/10.1177/20503121211002996

Ejemplares similares

Hypercoagulation in COPD: the clot thickens
por: Rahaghi, Farbod N., et al.
Publicado: (2021)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

Potential Mechanisms of Cancer-Related Hypercoagulability
por: Nasser, Nicola J., et al.
Publicado: (2020)

COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
por: Zhang, Shuoqi, et al.
Publicado: (2021)

THE CLOT THICKENS: DOES THE JOHNSON & JOHNSON COVID-19 VACCINE INCREASE THE RISK OF THROMBUS IN A HYPERCOAGULABLE STATE?
por: RUTENBERG, DAVID, et al.
Publicado: (2021)

Hypercoagulability of COVID-19 and Neurological Complications: A Review
por: Moore, Patrick, et al.
Publicado: (2022)

A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms
por: Kobayashi, Mayu, et al.
Publicado: (2021)

The Detection of Hypercoagulability in Patients with Acute Cerebral Infarction Using a Clot Waveform Analysis
por: Kamon, Toshitaka, et al.
Publicado: (2023)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
por: Randeria, Shehan N., et al.
Publicado: (2019)

The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate
por: Matsumoto, Takeshi, et al.
Publicado: (2023)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

The Hypercoagulable Profile of Organ Donors with Intravascular Clots Has a Similar Profile to COVID-19 and ICU Patients with Thrombotic Complications
por: Moore, Hunter B., et al.
Publicado: (2021)

COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis
por: Fan, Bingwen Eugene, et al.
Publicado: (2020)

Emerging patterns of hypercoagulability associated with critical COVID-19: A review
por: Frazer, John Scott, et al.
Publicado: (2020)

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management
por: Alam, Walid
Publicado: (2021)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
por: Cavanagh, Gregory, et al.
Publicado: (2020)

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Hypercoagulability in COVID-19: from an unknown beginning to future therapies
por: Duca, Ştefania-Teodora, et al.
Publicado: (2022)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders
por: Mongan, David, et al.
Publicado: (2020)

Reply to Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
por: Kolivras, Athanassios, et al.
Publicado: (2020)

Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
por: Bautista-Vargas, Mario, et al.
Publicado: (2020)

Narrative Review of Hypercoagulability in Small-Vessel Vasculitis
por: Claudel, Sophie E., et al.
Publicado: (2020)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
por: Jiang, Mingshan, et al.
Publicado: (2021)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Hypercoagulable State in COPD-A Comprehensive Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

COVID-19-Induced Hypercoagulability: A Case Report
por: Sperry, Bailey, et al.
Publicado: (2022)

Clotting and COVID-19
por: Bull, Todd M.
Publicado: (2021)

Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation
por: Ratano, Damian, et al.
Publicado: (2020)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Long lasting hypercoagulability after subclinical COVID-19
por: Ferroli, Paolo, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Clinical Features and Management of COVID-19–Associated Hypercoagulability
por: Massaro, Gianluca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c2071537q1gpc5no1cdc43etdv